Tag: Takeda Pharmaceutical Company
Takeda’s TAK-755 shows potential in Phase 3 trial for cTTP prophylaxis
Takeda Pharmaceutical Company has revealed promising interim results from its global Phase 3 trial of TAK-755, a recombinant ADAMTS13 protein in development for the prophylactic ... Read More
Takeda’s HYQVIA reduces CIDP relapse rates, Phase 3 trial reveals
Takeda Pharmaceutical Company has disclosed successful outcomes from its critical Phase 3 ADVANCE-CIDP 1 trial, focused on evaluating HYQVIA as a maintenance therapy for adults ... Read More
Takeda offers €520m to acquire European cell therapy company TiGenix
Pharma acquisition news : Japanese pharma company Takeda Pharmaceutical proposes to acquire TiGenix, a cell therapy company in Belgium for €520 million to grow its ... Read More